Structure Therapeutics Inc. American Depositary Shares vs. Johnson & Johnson
GPCR
Structure Therapeutics Inc. American Depositary Shares
$40.38 -14.70%
VS JNJJohnson & Johnson
$269.61 +0.18%
Johnson & Johnson (JNJ) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| GPCR | JNJ | |
|---|---|---|
| Market Cap | $2.88 billion | $648.55 billion |
| Revenue (TTM) | — | $97.93 billion |
| Net Income (TTM) | $-214,835,000 | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| GPCR | JNJ | |
|---|---|---|
| P/E Ratio | — | 31.28 |
| Price / Book | 2.13 | 7.63 |
| Price / Sales | — | 6.62 |
GPCR leads on 1 of 1 valuation factors.
Profitability
| GPCR | JNJ | |
|---|---|---|
| Net Margin | — | 21.48% |
| Return on Equity | -15.86% | 24.76% |
JNJ leads on 1 of 1 profitability factors.
Dividend
| GPCR | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.99% |
| Payout Ratio | — | 62.18 |
GPCR and JNJ split the dividend factors evenly.
Risk & Sentiment
| GPCR | JNJ | |
|---|---|---|
| Short Interest | 0.02% | 0.67% |
GPCR leads on 1 of 1 risk & sentiment factors.
Dig deeper: GPCR overview, GPCR financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.